Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Identification and validation of recurrence-associated endothelial cells utilizing a 54-gene panelAs step one in exploring the prognostic worth of TECs in PCa, we...
Jill Martin, a TODAY contributor, lately underwent breast reconstruction.TODAY contributor, Jill Martin, underwent breast reconstruction surgical procedure.Jill Martin, a life-style and commerce contributor...
